References
- ManninoDMBuistASGlobal burden of COPD: risk factors, prevalence, and future trendsLancet2007370958976577317765526
- SorianoJBRodríguez-RoisinRChronic obstructive pulmonary disease overviewProc Am Thorac Soc2011836336721816993
- MurphySLKochanekKDXuJQAriasEMortality in the United States, 2014NCHS data brief, no 229Hyattsville, MDNational Center for Health Statistics2015
- Dwyer-LindgrenLBertozzi-VillaAStubbsRWTrends and patterns of differences in chronic respiratory disease mortality among us counties, 1980–2014JAMA2017318121136114928973621
- VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- FosterTSMillerJDMartonJPCaloyerasJPRussellMWMenzinJAssessment of the economic burden of COPD in the US: A review and synthesis of the literatureCOPD2006321121817361502
- SchwabPDhamaneADHopsonSDImpact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis20171273574428260880
- DalalAAChristensenLLiuFRiedelAADirect costs of chronic obstructive pulmonary disease among managed care patientsInt J Chron Obstruct Pulmon Dis2010534134921037958
- FordESMurphyLBKhavjouOGilesWHHoltJBCroftJBTotal and state-specific medical and absenteeism costs of COPD among adults aged $18 years in the United States for 2010 and projections through 2020Chest20151471314525058738
- QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
- CrinerGJBourbeauJDiekemperRLExecutive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society GuidelineChest2015147488389325320966
- MahonJFitzgeraldAGlanvilleJMisuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future researchRespir Med20171299811628732842
- AroraPKumarLVohraVEvaluating the technique of using inhalation device in COPD and bronchial asthma patientsRespir Med2014108799299824873874
- VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Gold executive summaryAm J Respir Crit Care Med2017195555758228128970
- KlijnSLHiligsmannMEversSRomán-RodríguezMvan der MolenTvan BovenJFMEffectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic reviewNPJ Prim Care Respir Med20172712428408742
- SanchisJGichIPedersenSAerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use: Has patient technique improved over time?Chest2016150239440627060726
- KaplanAPriceDMatching inhaler devices with patients: The role of the primary care physicianCan Respir J20182018947305129951160
- JarvisSIndPWShinerRJInhaled therapy in elderly COPD patients; time for re-evaluation?Age Ageing200736221321817267450
- LohCHPetersSPLovingsTMOharJASuboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissionsAnn Am Thorac Soc20171481305131128406710
- MahlerDAWatermanLAGiffordAHPrevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhalerJ Aerosol Med Pulm Drug Deliv201326317417923025451
- SharmaGMahlerDAMayorgaVMDeeringKLHarshawOGanapathyVPrevalence of low peak inspiratory flow rate at discharge in patients hospitalized for copd exacerbationChronic Obstr Pulm Dis20174321722428848933
- MelaniASBonaviaMCilentiVInhaler mishandling remains common in real life and is associated with reduced disease controlRespir Med2011105693093821367593
- LewisATorvinenSDekhuijzenPNThe economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countriesBMC Health Serv Res20161625127406133
- KoserAWestermanJSharmaSEmmettACraterGDSafety and efficacy of fluticasone propionate/salmeterol hydrofluoroalkane 134a metered-dose-inhaler compared with fluticasone propionate/salmeterol diskus in patients with chronic obstructive pulmonary diseaseOpen Respir Med J20104869121253451
- JonesRMartinJThomasVThe comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database studyInt J Chron Obstruct Pulmon Dis2017122445245428860739
- AramakiEMiuraYTonoikeMExtraction of adverse drug effects from clinical recordsStud Health Technol Inform2010160Pt 173974320841784
- van AalderenWMGarcia-MarcosLGappaMHow to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheezeNPJ Prim Care Respir Med2015251408825568979
- PriceDChrystynHKaplanAEffectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary careAllergy Asthma Immunol Res20124418419122754711
- ThomasMPriceDChrystynHLloydAWilliamsAEvon ZiegenweidtJInhaled corticosteroids for asthma: impact of practice level device switching on asthma controlBMC Pulm Med20099119121204
- Advair hfatm (fluticasone propionate and salmeterol) [US package insert]Research triangle park NCGlaxosmithkline2017
- SpencerSEvansDJKarnerCCatesCJInhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201110CD007033
- BriggsAHGlickHALozano-OrtegaGIs treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH studyEur Respir J201035353253919717476
- HertelNKotchieRWSamyshkinYRadfordMHumphreysSJamesonKCost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysisInt J Chron Obstruct Pulmon Dis2012718319922500119
- Rutten-van MölkenMPMHGoossensLMACost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary diseasePharmacoeconomics201230427130222409290
- CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
- DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
- PriceDRocheNChristian VirchowJDevice type and real-world effectiveness of asthma combination therapy: an observational studyRespir Med2011105101457146621612903
- RachelefskyGSLiaoYFaruqiRImpact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysisAnn Allergy Asthma Immunol200798322523817378253
- DekhuijzenPNRBatsiouMBjermerLIncidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and deviceRespir Med2016120546327817816
- van BovenJFde Jong-van den BergLTVegterSInhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysisDrug Saf201336423123623516006
- BroedersMEMolemaJHopWCVermueNAFolgeringHTThe course of inhalation profiles during an exacerbation of obstructive lung diseaseRespir Med200498121173117915588037
- BorgströmLAskingLLipniunasPAn in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditionsJ Aerosol Med200518330431016181005
- JansonCLööfTTelgGStratelisGNilssonFDifference in resistance to humidity between commonly used dry powder inhalers: an in vitro studyNPJ Prim Care Respir Med2016261605327853177
- SteinBDBautistaASchumockGTThe validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbationsChest20121411879321757568
- GindeAATsaiCLBlancPGCamargoCAPositive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency departmentJt Comm J Qual Patient Saf2008341167868019025089